Wells Fargo lowered the firm’s price target on Varonis (VRNS) to $46 from $48 and keeps an Equal Weight rating on the shares. Shares of Varonis traded down after market close on mixed Q4 results. While the SaaS transition is accelerating, the impact from GenAI remains small and ARR growth is decelerating to just 15% in CY25, which does not yet warrant a premium valuation.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS: